Familial hypercholesterolemia (suspected)

This ratio evaluates overall cholesterol relative to protective HDL cholesterol. It is a commonly used measure of lipid-related cardiovascular risk.

Non-HDL cholesterol represents all potentially atherogenic lipoproteins, calculated by subtracting HDL from total cholesterol. It includes LDL, VLDL, and other cholesterol-carrying particles associated with cardiovascular risk.

Known as "bad cholesterol," it can accumulate in arterial walls, forming plaques that narrow blood vessels and increase risk of heart attack and stroke.

The overall amount of cholesterol in your bloodstream. High levels can increase risk of heart disease.

A quantitative assessment of calcium-containing plaque in coronary arteries, detected by CT scanning. Serves as an indicator of atherosclerosis progression and cardiovascular risk independent of traditional risk factors.

A protein found on the surface of all atherogenic lipoproteins including LDL. Since each ApoB particle contains one lipoprotein, ApoB levels directly reflect the number of potentially harmful particles in circulation. Elevated levels strongly correlate with increased cardiovascular risk, and often provide a more accurate risk assessment than LDL alone.

A calculated ratio comparing "bad" cholesterol (LDL) to "good" cholesterol (HDL). providing a single metric that reflects the balance between cholesterol delivery to tissues and cholesterol removal from arterial walls. This ratio integrates both atherogenic and protective lipid factors into one value that indicates net cardiovascular risk.